Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients.

Possible Role of Coenzyme Q10 in Prevention of Contrast Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Coronary Angiography With or Without Intervention.

In this study the investigators aim to study the effect of supplementation of CoQ10 in decreasing the incidence of contrast induced acute kidney injury in patients with acute coronary syndrome undergoing coronary angiography.

Patients who fulfilled the inclusion criteria and agreed to participate in the study will be randomly divided into 2 groups using their computer generated random numbers that group a will receive the coenzyme Q10 in addition to the standard preventive measures and group b will receive only the standard preventive measures without the coenzyme Q10.

Inclusion Criteria:

• Patients who are 18 years or older.
• ST-elevation myocardial infarction (STEMI).
• Non ST-elevation myocardial infarction( NSTEMI).
• Unstable Angina (UA)

Exclusion Criteria:

• Renal transplant patients.
• Preoperative bleeding .
• Intraoperative bleeding or hypotension.
• Patients taking any nephrotoxic medications